Variant report

Variant	nsv551873
Chromosome Location	chr10:90946059-90964395
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr10:90807595..90810361-chr10:90944518..90946449,2	MCF-7	breast:

Extended variants
information (count: 312 )
Associated
traits (count: 90 )

Variant overlapped rSNPs/rCNVs (count:312 , 50 per page) page: 1 2 3 4 5 6 7

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs536095352	chr10:90946101-90946102	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs141509625	chr10:90946102-90946103	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs187270280	chr10:90946209-90946210	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs545860698	chr10:90946229-90946230	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs564141320	chr10:90946277-90946278	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs572859019	chr10:90946314-90946315	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs147522393	chr10:90946365-90946366	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs191724897	chr10:90946368-90946369	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs181858420	chr10:90946400-90946401	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs139549044	chr10:90946427-90946428	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs185433046	chr10:90946455-90946456	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs372956901	chr10:90946466-90946467	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs533081161	chr10:90946479-90946480	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs551449434	chr10:90946491-90946492	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs113138797	chr10:90946609-90946610	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs566484588	chr10:90946616-90946617	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs145086629	chr10:90946617-90946618	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs548996928	chr10:90946689-90946690	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs568766766	chr10:90946704-90946705	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs3923282	chr10:90946752-90946753	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs557547123	chr10:90946790-90946791	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs575723233	chr10:90946797-90946798	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs147166644	chr10:90946832-90946833	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs557869783	chr10:90946876-90946877	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs536138375	chr10:90946954-90946955	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs10749598	chr10:90946988-90946989	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs540256377	chr10:90947060-90947061	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs561663662	chr10:90947068-90947069	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs531793778	chr10:90947075-90947076	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs572648887	chr10:90947114-90947115	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs201124229	chr10:90947140-90947141	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs12257259	chr10:90947171-90947172	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs544149082	chr10:90947190-90947191	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs562704657	chr10:90947201-90947202	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs139446656	chr10:90947204-90947205	Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs545216360	chr10:90947237-90947238	Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs373058461	chr10:90947278-90947279	Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs560335701	chr10:90947291-90947292	Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs190287736	chr10:90947339-90947340	Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs149670223	chr10:90947345-90947346	Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs544060664	chr10:90947360-90947361	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs567119773	chr10:90947408-90947409	Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs182529695	chr10:90947444-90947445	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs535872388	chr10:90947507-90947508	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs569195906	chr10:90947518-90947519	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs539689343	chr10:90947533-90947534	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs562544862	chr10:90947599-90947600	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs186485548	chr10:90947636-90947637	Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs566658893	chr10:90947644-90947645	Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs533995778	chr10:90947729-90947730	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:90)

Disease	PMID	Source
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
Prostate cancer	18632612	CNVD
Cockayne syndrome	18421352	CNVD
Glioblastoma	16823260	CNVD
Medulloblastoma	16968546	CNVD
Neuroblastoma	17533364	CNVD
Squamous cell cancer	21044232	CNVD
Glioma	21971842	CNVD
Cancer	21637783	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Lung cancer	18438408	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Usher syndrome	20538994	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21785460	CNVD
Acute myeloid leukemia	20729466	CNVD
Prostate cancer	16573809	CNVD
Paraganglioma	17535989	CNVD
Submicroscopic aberration syndrome	21292638	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Pulmonary chondroma	17535989	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Colorectal cancer	18645599	CNVD
Polyposis syndrome	18645599	CNVD
Prostate cancer	17245344	CNVD
Glioblastoma multiforme	17369134	CNVD
Glioblastoma multiforme	21750150	CNVD
Breast cancer	22032731	CNVD
Ovarian cancer	20844748	CNVD
Glioblastoma multiforme	17002787	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	17387387	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21364760	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Wilms tumour	21544195	CNVD
Cancer	20164919	CNVD
small cell lung cancer	20016488	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Colorectal cancer	19359472	CNVD
Neurocytoma	17123091	CNVD
Prostate cancer	16461572	CNVD
Basal-like breast cancer	18066063	CNVD
Effusion lymphoma	18079361	CNVD
Lung cancer	21911935	CNVD
Myelofibrosis	22110671	CNVD
Prostate cancer	21088497	CNVD
Breast cancer	22048815	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Glioblastoma multiforme	22291905	CNVD
Glioblastoma multiforme	19435819	CNVD
Glioblastoma multiforme	22286061	CNVD
Intracranial ependymoma	16609018	CNVD
Breast cancer	16397240	CNVD
Chronic lymphocytic leukemia	21049055	CNVD
Cervical cancer	21062161	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	24453001	CNVD
Breast cancer	16608533	CNVD
Sezary syndrome	18413736	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Bipolar disorder	19114987	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	22522925	CNVD
T-cell lymphomas	22341440	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:43 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:90944400-90949400	Enhancers	Breast Myoepithelial Primary Cells	Breast
2	chr10:90945400-90946600	Enhancers	Fetal Lung	lung
3	chr10:90946200-90947200	Enhancers	iPS-18 Cell Line	embryonic stem cell
4	chr10:90946400-90946800	Enhancers	iPS-15b Cell Line	embryonic stem cell
5	chr10:90946400-90947000	Enhancers	H1 Cell Line	embryonic stem cell
6	chr10:90946400-90947000	Enhancers	H9 Cell Line	embryonic stem cell
7	chr10:90955200-90956000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
8	chr10:90960800-90962200	Enhancers	NHEK	skin
9	chr10:90961000-90961600	Enhancers	NHDF-Ad	bronchial
10	chr10:90961000-90961800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
11	chr10:90961000-90962200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
12	chr10:90961000-90962200	Enhancers	NHLF	lung
13	chr10:90961200-90961600	Enhancers	A549	lung
14	chr10:90961200-90962200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
15	chr10:90961400-90962000	Enhancers	Fetal Stomach	stomach
16	chr10:90961400-90962200	Enhancers	HMEC	breast
17	chr10:90961400-90962400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
18	chr10:90961600-90961800	Enhancers	Sigmoid Colon	Sigmoid Colon
19	chr10:90961600-90962200	Enhancers	Breast Myoepithelial Primary Cells	Breast
20	chr10:90961600-90962400	Enhancers	Esophagus	oesophagus
21	chr10:90961600-90963000	Weak transcription	NHDF-Ad	bronchial
22	chr10:90961800-90963000	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
23	chr10:90962200-90963200	Weak transcription	NHLF	lung
24	chr10:90962400-90963400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
25	chr10:90962400-90966200	Weak transcription	Esophagus	oesophagus
26	chr10:90962800-90963000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
27	chr10:90963000-90963200	Enhancers	NHDF-Ad	bronchial
28	chr10:90963000-90963600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
29	chr10:90963000-90964000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
30	chr10:90963200-90963800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
31	chr10:90963200-90963800	Enhancers	NHLF	lung
32	chr10:90963400-90963600	Bivalent/Poised TSS	NHDF-Ad	bronchial
33	chr10:90963400-90963800	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
34	chr10:90963400-90963800	Bivalent Enhancer	Fetal Thymus	thymus
35	chr10:90963400-90964000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
36	chr10:90963600-90963800	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
37	chr10:90963600-90963800	Bivalent Enhancer	Aorta	Aorta
38	chr10:90963800-90964000	Enhancers	ES-I3 Cell Line	embryonic stem cell
39	chr10:90963800-90964000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
40	chr10:90963800-90965000	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
41	chr10:90963800-90965800	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
42	chr10:90964000-90964400	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
43	chr10:90964200-90964400	Bivalent Enhancer	H1 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links